Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Can the potential benefit of individualizing treatment be assessed using trial summary statistics alone?

American Journal of Epidemiology(2024)10.1093/aje/kwae040Source: DataRank Database

Can the potential benefit of individualizing treatment be assessed using trial summary statistics alone? is a research paper published in American Journal of Epidemiology (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: bronzeTopics (40)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Marco Carone ORCID,Ronald C. Kessler ORCID,Alex Luedtke ORCID,Nina Galanter ORCID

Live enrichment

PubMed:38679458 OpenAlex:https://openalex.org/W4396229818

National Institutes of Health

Grant: DP2LM013340

National Institutes of Health

Grant: R01HL137808

National Institutes of Health

Grant: T32ES015459

National Science Foundation

Grant: DGE-1762114

National Institutes of Health

Grant: 5T32ES015459-09

Biostatistics, Epidemiologic & Bioinformatic Training in Environmental Health

National Science Foundation

Grant: 1762114

Graduate Research Fellowship Program (GRFP)

National Institutes of Health

Grant: 1DP2LM013340-01

High-Resolution Inference for Correlates of Vaccine Protection

FWCI

0.00

Citation Percentile

0.1%

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/aje/article-pdf/193/8/1161/58718802/kwae040.pdf

publisherhttps://academic.oup.com/aje/article-pdf/193/8/1161/58718802/kwae040.pdf

publisherhttps://academic.oup.com/aje/advance-article-pdf/doi/10.1093/aje/kwae040/58437684/kwae040.pdf

journalhttps://doi.org/10.1093/aje/kwae040

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38679458

Fields of Study

Treatment of Major DepressionHealth Systems, Economic Evaluations, Quality of LifeMental Health Research Topics01 natural sciences03 medical and health sciences0302 clinical medicine0101 mathematics

MeSH Terms

Antidepressive AgentsClinical Trials as TopicData Interpretation, StatisticalMajor Depressive DisorderDepressive Disorder, MajorHumansModels, StatisticalRandomized Controlled Trials as TopicTreatment OutcomePrecision Medicine

Keywords

CovariateStatisticsClinical trialSummary statisticsMedicineOutcome (game theory)EconometricsMathematicsInternal medicineFOS: Computer and information sciencesClinical Trials as TopicModels, StatisticalMajor Depressive DisorderStatistics - ApplicationsAntidepressive AgentsMethodology (stat.ME)Treatment OutcomeData Interpretation, StatisticalHumansApplications (stat.AP)Precision MedicineStatistics - MethodologyRandomized Controlled Trials as Topic

Sustainable Development Goals

SDG 3: 3. Good health